NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
125 hedge funds and large institutions have $246M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 62 increasing their positions, 22 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
64% less capital invested
Capital invested by funds: $690M → $246M (-$444M)
Holders
125
Holding in Top 10
2
Calls
$1.32M
Puts
$3K
Top Buyers
| 1 | +$29.6M | |
| 2 | +$3.03M | |
| 3 | +$2.96M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.91M |
| 5 |
Millennium Management
New York
|
+$1.14M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$21.5M | |
| 3 | -$12.5M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$11.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.75M |